Login / Signup
Anne Bauters
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 4
Top Topics
Peritoneal Dialysis
Drug Administration
Chronic Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Top Venues
Leukemia & lymphoma
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alexandre Butelet
,
Stéphanie Poulain
,
Emmanuelle Jeanpierre
,
Micha Srour
,
Morgane Nudel
,
Paul Chauvet
,
Anne Bauters
,
Sophie Susen
,
Annabelle Dupont
,
Marie de Charette
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Leukemia & lymphoma
63 (13) (2022)
Alexandre Butelet
,
Stéphanie Poulain
,
Emmanuelle Jeanpierre
,
Micha Srour
,
Morgane Nudel
,
Paul Chauvet
,
Anne Bauters
,
Sophie Susen
,
Annabelle Dupont
,
Marie de Charette
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Leukemia & lymphoma
63 (13) (2022)
Alexandre Butelet
,
Stéphanie Poulain
,
Emmanuelle Jeanpierre
,
Micha Srour
,
Morgane Nudel
,
Paul Chauvet
,
Anne Bauters
,
Sophie Susen
,
Annabelle Dupont
,
Marie de Charette
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Leukemia & lymphoma
63 (13) (2022)
Alexandre Butelet
,
Stéphanie Poulain
,
Emmanuelle Jeanpierre
,
Micha Srour
,
Morgane Nudel
,
Paul Chauvet
,
Anne Bauters
,
Sophie Susen
,
Annabelle Dupont
,
Marie de Charette
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Leukemia & lymphoma
63 (13) (2022)